This Grand Rounds discussion outlines a case-based, guideline-informed approach to managing frequent migraine, highlighting accurate diagnosis, stratification of attack frequency, and integration of acute and preventive therapies. Experts highlight evolving treatment strategies, including triptans and calcitonin gene–related peptide–targeting agents, alongside traditional pharmacologic options, to individualize care and reduce disease burden.

Source: Annals of Internal Medicine